Literature DB >> 26581228

Expanding the Clinical and Genetic Spectrum of KRT1, KRT2 and KRT10 Mutations in Keratinopathic Ichthyosis.

Alrun Hotz1, Vinzenz Oji, Emmanuelle Bourrat, Nathalie Jonca, Juliette Mazereeuw-Hautier, Regina C Betz, Ulrike Blume-Peytavi, Karola Stieler, Fanny Morice-Picard, Ines Schönbuchner, Susanne Markus, Nina Schlipf, Judith Fischer.   

Abstract

Twenty-six families with keratinopathic ichthyoses (epidermolytic ichthyosis, superficial epidermolytic ichthyosis or congenital reticular ichthyosiform erythroderma) were studied. Epidermolytic ichthyosis is caused by mutations in the genes KRT1 or KRT10, mutations in the gene KRT2 lead to superficial epidermolytic ichthyosis, and congenital reticular ichthyosiform erythroderma is caused by frameshift mutations in the genes KRT10 or KRT1, which lead to the phenomenon of revertant mosaicism. In this study mutations were found in KRT1, KRT2 and KRT10, including 8 mutations that are novel pathogenic variants. We report here the first case of a patient with congenital reticular ichthyosiform erythroderma carrying a mutation in KRT10 that does not lead to an arginine-rich reading frame. Novel clinical features found in patients with congenital reticular ichthyosiform erythroderma are described, such as mental retardation, spasticity, facial dysmorphisms, symblepharon and malposition of the 4th toe.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26581228     DOI: 10.2340/00015555-2299

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  17 in total

Review 1.  [Red, scaly baby: a pediatric dermatological emergency : Clinical and differential diagnoses of neonatal erythroderma].

Authors:  H Ott; J Grothaus
Journal:  Hautarzt       Date:  2017-10       Impact factor: 0.751

2.  Chromosomal inversions as a hidden disease-modifying factor for somatic recombination phenotypes.

Authors:  Toshifumi Nomura; Shotaro Suzuki; Toshinari Miyauchi; Masae Takeda; Satoru Shinkuma; Yasuyuki Fujita; Wataru Nishie; Masashi Akiyama; Hiroshi Shimizu
Journal:  JCI Insight       Date:  2018-03-22

Review 3.  Revertant mosaicism in genodermatoses.

Authors:  Young H Lim; Jonathan M Fisher; Keith A Choate
Journal:  Cell Mol Life Sci       Date:  2017-02-06       Impact factor: 9.261

4.  Expanding the Mutation Spectrum of Ichthyosis with Confetti.

Authors:  Young H Lim; Keith A Choate
Journal:  J Invest Dermatol       Date:  2016-10       Impact factor: 8.551

5.  Novel and recurrent mutations in keratin 1 cause epidermolytic ichthyosis and palmoplantar keratoderma.

Authors:  F J D Smith; I M Kreuser-Genis; C S Jury; N J Wilson; A Terron-Kwiatowski; M Zamiri
Journal:  Clin Exp Dermatol       Date:  2018-10-04       Impact factor: 3.470

6.  Genetic Reversion via Mitotic Recombination in Ichthyosis with Confetti due to a KRT10 Polyalanine Frameshift Mutation.

Authors:  Young H Lim; Jingyao Qiu; Corey Saraceni; Barbara A Burrall; Keith A Choate
Journal:  J Invest Dermatol       Date:  2016-05-18       Impact factor: 8.551

7.  Mutations in SULT2B1 Cause Autosomal-Recessive Congenital Ichthyosis in Humans.

Authors:  Lisa Heinz; Gwang-Jin Kim; Slaheddine Marrakchi; Julie Christiansen; Hamida Turki; Marc-Alexander Rauschendorf; Mark Lathrop; Ingrid Hausser; Andreas D Zimmer; Judith Fischer
Journal:  Am J Hum Genet       Date:  2017-06-01       Impact factor: 11.025

8.  Recurrent KRT10 Variant in Ichthyosis with Confetti.

Authors:  Takuya Takeichi; Yasushi Suga; Takashi Mizuno; Yusuke Okuno; Daisuke Ichikawa; Michihiro Kono; John Y W Lee; John A McGrath; Masashi Akiyama
Journal:  Acta Derm Venereol       Date:  2020-07-02       Impact factor: 3.875

Review 9.  Inherited Nonsyndromic Ichthyoses: An Update on Pathophysiology, Diagnosis and Treatment.

Authors:  Anders Vahlquist; Judith Fischer; Hans Törmä
Journal:  Am J Clin Dermatol       Date:  2018-02       Impact factor: 7.403

10.  A "late-but-fitter revertant cell" explains the high frequency of revertant mosaicism in epidermolysis bullosa.

Authors:  Peter C van den Akker; Anna M G Pasmooij; Hans Joenje; Robert M W Hofstra; Gerard J Te Meerman; Marcel F Jonkman
Journal:  PLoS One       Date:  2018-02-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.